Skip to main content

Table 2 Forecasting the prevalence (95 % confidence interval) of MS from 2020 to 2029 (prevalence in 100,000 population)

From: Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series

Year Total MS Familial MS Sporadic MS
2020 189.50(183.94-195.14) 25.69(24.97–26.45) 163.74(159.06-168.57)
2021 193.00(184.6-201.28) 26.26(25.18–27.39) 166.6(159.61-173.82)
2022 196.50(184.42-208.02) 26.83(25.23–28.35) 169.45(159.15-179.16)
2023 199.97(183.79-215.27) 27.4(25.24–29.49) 172.32(158.38-185.68)
2024 203.45(182.7-222.98) 27.96(25.17–30.61) 175.11(157.29-192.05)
2025 206.93(181.19-231.26) 28.53(25.1-31.83) 177.96(155.73-199.19)
2026 210.41(179.31-239.54) 29.09(24.92–33.11) 180.82(154.02–206.5)
2027 213.87(176.92-248.41) 29.66(24.72–34.46) 183.63(151.76-214.43)
2028 217.36(174.36–257.50) 30.23(24.47–35.72) 186.51(149.58-221.73)
2029 220.84(171.48-266.92) 30.79(24.16–37.15) 189.33(146.97-230.19)